Nifty
Sensex
:
:
18562.75
62504.80
50.00 (0.27%)
211.16 (0.34%)

Pharmaceuticals & Drugs - Global

Rating :
34/99

BSE: 506197 | NSE: BLISSGVS

71.75
28-Nov-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 71.30
  • 72.75
  • 71.15
  • 71.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  126421
  •  90.91
  •  119.00
  •  66.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 749.90
  • 81.95
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 677.33
  • 0.69%
  • 0.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.55%
  • 7.40%
  • 30.57%
  • FII
  • DII
  • Others
  • 16.68%
  • 6.64%
  • 4.16%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.54
  • -1.71
  • 2.74

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.63
  • -9.70
  • -0.82

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -12.58
  • -23.86
  • -46.33

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.52
  • 18.70
  • 16.78

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.69
  • 2.06
  • 1.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.97
  • 8.10
  • 8.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
172.43
195.99
-12.02%
188.66
168.15
12.20%
167.06
132.05
26.51%
216.26
164.06
31.82%
Expenses
147.88
166.58
-11.23%
149.81
133.54
12.18%
146.90
115.17
27.55%
182.09
125.78
44.77%
EBITDA
24.55
29.41
-16.52%
38.85
34.60
12.28%
20.17
16.88
19.49%
34.16
38.28
-10.76%
EBIDTM
14.23%
15.00%
20.59%
20.58%
12.07%
12.79%
15.80%
23.33%
Other Income
2.15
5.45
-60.55%
7.01
7.82
-10.36%
12.19
6.33
92.58%
6.04
4.12
46.60%
Interest
1.91
0.68
180.88%
2.11
1.40
50.71%
1.63
2.36
-30.93%
1.04
0.94
10.64%
Depreciation
4.60
4.30
6.98%
4.55
4.33
5.08%
4.27
4.27
0.00%
4.43
4.36
1.61%
PBT
20.19
29.89
-32.45%
39.20
36.69
6.84%
26.45
16.58
59.53%
-38.86
37.09
-
Tax
4.19
7.83
-46.49%
11.72
10.55
11.09%
2.99
8.43
-64.53%
9.67
9.53
1.47%
PAT
16.00
22.06
-27.47%
27.48
26.13
5.17%
23.47
8.15
187.98%
-48.53
27.56
-
PATM
9.28%
11.25%
14.56%
15.54%
14.05%
6.17%
-22.44%
16.80%
EPS
1.33
2.05
-35.12%
2.48
2.35
5.53%
1.89
0.61
209.84%
-4.83
2.48
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
744.41
747.45
577.21
689.31
898.57
814.64
798.44
546.89
407.13
344.64
396.63
Net Sales Growth
12.75%
29.49%
-16.26%
-23.29%
10.30%
2.03%
46.00%
34.33%
18.13%
-13.11%
 
Cost Of Goods Sold
389.21
390.98
329.71
439.97
612.26
391.13
358.93
237.18
152.77
132.01
167.90
Gross Profit
355.20
356.47
247.49
249.34
286.31
423.52
439.51
309.72
254.37
212.63
228.72
GP Margin
47.72%
47.69%
42.88%
36.17%
31.86%
51.99%
55.05%
56.63%
62.48%
61.70%
57.67%
Total Expenditure
626.68
629.11
470.56
565.99
740.93
617.50
595.70
391.17
303.70
273.42
285.47
Power & Fuel Cost
-
8.25
8.14
5.88
4.76
5.49
5.58
4.72
4.36
2.93
2.18
% Of Sales
-
1.10%
1.41%
0.85%
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
0.55%
Employee Cost
-
76.15
68.09
53.69
42.32
69.23
61.35
33.74
29.43
23.46
15.08
% Of Sales
-
10.19%
11.80%
7.79%
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
3.80%
Manufacturing Exp.
-
12.09
7.83
7.07
4.95
4.88
5.39
25.65
29.98
41.44
37.17
% Of Sales
-
1.62%
1.36%
1.03%
0.55%
0.60%
0.68%
4.69%
7.36%
12.02%
9.37%
General & Admin Exp.
-
15.22
12.03
13.27
17.05
39.48
36.36
24.68
17.07
15.16
14.63
% Of Sales
-
2.04%
2.08%
1.93%
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
3.69%
Selling & Distn. Exp.
-
66.56
31.35
28.83
34.72
62.09
92.46
42.51
47.05
35.12
40.26
% Of Sales
-
8.90%
5.43%
4.18%
3.86%
7.62%
11.58%
7.77%
11.56%
10.19%
10.15%
Miscellaneous Exp.
-
59.86
13.40
17.28
24.86
45.21
35.63
22.71
23.03
23.30
40.26
% Of Sales
-
8.01%
2.32%
2.51%
2.77%
5.55%
4.46%
4.15%
5.66%
6.76%
2.08%
EBITDA
117.73
118.34
106.65
123.32
157.64
197.14
202.74
155.72
103.43
71.22
111.16
EBITDA Margin
15.82%
15.83%
18.48%
17.89%
17.54%
24.20%
25.39%
28.47%
25.40%
20.67%
28.03%
Other Income
27.39
31.49
21.95
39.19
37.63
26.54
12.51
24.35
20.29
28.00
14.07
Interest
6.69
4.74
7.24
7.57
4.41
22.80
19.69
18.61
16.41
17.98
9.72
Depreciation
17.85
17.33
17.23
12.59
8.94
21.38
20.14
13.26
11.30
10.68
6.03
PBT
46.98
127.76
104.13
142.35
181.92
179.49
175.40
148.19
96.02
70.56
109.48
Tax
28.57
31.04
30.16
33.71
55.25
56.63
62.72
48.05
34.63
29.53
49.90
Tax Rate
60.81%
57.30%
28.96%
26.14%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
45.58%
PAT
18.42
15.04
68.49
97.26
123.72
58.78
82.04
82.49
59.91
40.99
57.72
PAT before Minority Interest
9.09
23.13
73.97
95.25
126.66
88.66
112.68
100.15
61.39
41.03
59.58
Minority Interest
-9.33
-8.09
-5.48
2.01
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
-1.86
PAT Margin
2.47%
2.01%
11.87%
14.11%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
14.55%
PAT Growth
-78.05%
-78.04%
-29.58%
-21.39%
110.48%
-28.35%
-0.55%
37.69%
46.16%
-28.98%
 
EPS
1.77
1.45
6.59
9.36
11.91
5.66
7.90
7.94
5.77
3.95
5.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
818.70
808.25
735.61
646.00
536.24
486.62
412.62
337.08
286.88
258.01
Share Capital
10.37
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
798.40
788.10
725.30
635.68
525.92
476.31
402.31
326.77
276.57
247.69
Non-Current Liabilities
29.20
45.24
46.32
37.99
12.92
32.81
49.55
67.52
95.65
96.92
Secured Loans
23.22
32.60
37.24
32.54
5.92
25.58
29.62
55.03
78.80
89.97
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
8.62
2.23
8.79
1.33
Long Term Provisions
1.07
2.50
2.44
1.75
1.91
2.05
1.81
1.40
1.10
0.74
Current Liabilities
233.09
203.64
230.53
207.03
299.40
437.09
378.97
242.68
307.66
202.19
Trade Payables
92.61
74.22
89.92
78.88
58.43
98.25
108.49
80.33
82.35
118.15
Other Current Liabilities
67.85
53.69
57.21
50.24
124.46
99.93
52.76
70.30
42.12
24.45
Short Term Borrowings
60.70
65.04
66.39
64.30
105.66
187.47
62.12
61.04
57.05
45.16
Short Term Provisions
11.93
10.69
17.01
13.61
10.85
51.45
155.60
31.00
126.14
14.44
Total Liabilities
1,108.75
1,076.79
1,027.22
904.88
860.04
1,022.90
874.24
662.17
700.35
570.92
Net Block
280.76
233.72
240.97
144.97
136.48
303.86
225.25
234.38
213.31
168.23
Gross Block
343.41
285.10
276.07
169.89
157.47
326.83
300.74
293.82
262.45
205.92
Accumulated Depreciation
62.65
51.38
35.10
24.92
20.99
22.97
75.48
59.44
49.14
37.69
Non Current Assets
332.71
311.59
257.48
211.39
170.25
456.97
291.23
244.66
229.67
219.61
Capital Work in Progress
22.15
2.39
0.00
46.74
0.47
4.03
9.10
0.00
4.33
0.65
Non Current Investment
3.08
0.70
0.72
0.72
6.30
1.05
0.11
0.01
0.01
0.01
Long Term Loans & Adv.
25.25
12.63
14.56
18.63
26.72
11.45
56.77
10.27
12.02
50.72
Other Non Current Assets
1.47
62.15
1.24
0.33
0.29
136.58
0.00
0.00
0.00
0.00
Current Assets
776.03
765.20
769.74
693.49
689.79
565.93
583.00
417.08
469.26
348.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
123.94
98.93
74.14
77.37
59.03
49.30
38.67
33.70
32.53
32.52
Sundry Debtors
392.75
463.82
547.91
460.73
298.48
254.45
300.93
247.47
215.03
244.64
Cash & Bank
177.53
144.55
103.32
106.63
88.86
150.50
78.18
57.29
80.37
50.35
Other Current Assets
81.82
17.55
16.13
26.21
243.41
111.68
165.22
78.62
141.34
21.37
Short Term Loans & Adv.
67.70
40.35
28.24
22.55
146.30
78.44
149.92
60.69
130.30
8.92
Net Current Assets
542.95
561.56
539.21
486.47
390.39
128.84
204.03
174.40
161.60
146.70
Total Assets
1,108.74
1,076.79
1,027.22
904.88
860.04
1,022.90
874.23
662.17
700.35
570.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
135.48
63.97
46.70
39.95
17.64
289.47
112.95
48.94
41.15
6.50
PBT
127.76
104.13
128.97
181.91
179.49
175.40
148.19
96.02
70.56
109.48
Adjustment
-31.71
46.29
26.85
-10.97
17.55
36.24
18.18
22.48
24.11
9.71
Changes in Working Capital
73.37
-57.89
-70.32
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
-73.94
Cash after chg. in Working capital
169.42
92.53
85.49
-12.13
56.24
325.13
158.05
57.56
75.36
45.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-33.94
-28.56
-38.79
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
-38.75
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-92.98
-46.99
-47.89
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
-124.05
Net Fixed Assets
-78.37
-10.99
-65.98
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
-12.91
Net Investments
0.05
0.01
0.01
0.16
2.37
-0.95
-1.36
0.00
-0.01
-18.19
Others
-14.66
-36.01
18.08
-21.20
48.91
-272.38
-43.16
-10.20
1.97
-92.95
Cash from Financing Activity
-23.73
-20.80
-6.30
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
109.89
Net Cash Inflow / Outflow
18.78
-3.82
-7.50
-16.74
-8.10
48.09
22.85
-33.31
21.77
-7.66
Opening Cash & Equivalents
13.13
15.34
15.04
36.95
47.41
0.00
5.09
49.57
27.79
58.01
Closing Cash & Equivalent
21.99
13.13
15.34
15.04
36.95
47.41
27.60
16.26
49.57
50.35

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
78.01
77.41
71.32
62.63
51.99
47.18
40.00
32.64
27.67
24.78
ROA
2.12%
7.03%
9.86%
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
13.53%
ROE
2.88%
9.64%
13.79%
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
25.56%
ROCE
6.37%
12.49%
17.02%
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
36.18%
Fixed Asset Turnover
2.38
2.06
3.09
5.49
3.37
2.56
1.85
1.47
1.48
2.95
Receivable days
209.14
319.89
267.05
154.20
123.80
126.33
182.13
206.07
241.81
171.03
Inventory Days
54.42
54.72
40.11
27.70
24.25
20.01
24.04
29.51
34.22
20.71
Payable days
77.87
90.85
56.62
35.01
51.74
67.63
95.25
108.77
148.76
105.12
Cash Conversion Cycle
185.69
283.75
250.53
146.89
96.31
78.70
110.92
126.81
127.26
86.63
Total Debt/Equity
0.13
0.15
0.16
0.16
0.22
0.46
0.32
0.47
0.60
0.58
Interest Cover
12.42
15.38
18.04
42.21
7.37
9.91
8.96
6.85
4.92
12.27

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.